Cargando…
Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C
Reducing the treatment duration for chronic hepatitis C could be an important tool in the effort to reach the elimination goals set by the World Health Organization. The current challenge is to predict the target group who will achieve sustained virological response at week 12 (SVR12) with shorter t...
Autores principales: | Madsen, Lone Wulff, Christensen, Peer Brehm, Øvrehus, Anne, Bryde, Dorthe Marie Sjødahl, Holm, Dorte Kinggaard, Lillevang, Søren Thue, Nielsen, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271618/ https://www.ncbi.nlm.nih.gov/pubmed/35832377 http://dx.doi.org/10.3389/fcimb.2022.885824 |
Ejemplares similares
-
Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life
por: Mössner, Belinda K, et al.
Publicado: (2016) -
A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project
por: Dröse, Sandra, et al.
Publicado: (2022) -
Incidence, prevalence and risk factors for hepatitis C in Danish prisons
por: Søholm, Jacob, et al.
Publicado: (2019) -
Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021) -
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
por: Madsen, Lone W., et al.
Publicado: (2022)